Orange Health Labs

An eMedic arrives at the patient's home within 30 minutes of booking to draw samples.

Reports are reviewed by an in-house medical team and delivered fast for nearly all orders.

Orange Health owns the entire diagnostics chain instead of outsourcing collection, targeting a key source of diagnostic error.

Positioned against both traditional labs, where patients must travel, and unreliable home-collection rivals.

Direct-to-consumer bookings via the Orange Health app and website form the largest share of the business.

B2B relationships with corporate wellness programs, insurers, employers and partner platforms.

Independent doctors and clinics use Orange Health's proprietary platform to order diagnostics for their patients.

Reports are checked by Orange Health's own in-house medical team before release, rather than outsourced.

Patients can track their eMedic live and auto-share reports with their doctor.

Company reports strong loyalty and satisfaction metrics since inception.

Primary direct-to-consumer booking channel for scheduling home sample collection.

A trained field workforce performs at-home sample collection across cities.

Physical collection centres supplementing the home-collection model, expanded since 2024.

Exclusive diagnostics distribution partner on Amazon's pharmacy and diagnostics vertical.

Coordinating eMedic dispatch and transport of samples to labs within a temperature-controlled window.

Running diagnostic tests and producing reviewed reports within a 6-hour SLA.

Hiring and training a large field phlebotomy workforce to a consistent standard.

Building in-house tools such as NeO Reports and AI-driven logistics/report-processing software.

Orange Health operates its own accredited testing labs rather than outsourcing.

Trained, background-verified phlebotomy staff, each completing around 100 hours of training.

Proprietary software assigns the nearest eMedic, optimises routing and speeds up report processing.

Certified data security posture protecting patient health records.

Exclusive diagnostics partner for Amazon's pharmacy and diagnostics vertical; one of 150+ platform/corporate partners.

Independent clinics and doctors use Orange Health's proprietary platform to order tests for patients.

Backed by Y Combinator, Accel, General Catalyst, Bertelsmann India Investments and Amazon's Smbhav Venture Fund (plus Iron Pillar as of the Series C round).

Pay-per-test bookings through the app/website make up the bulk of revenue.

B2B2C revenue via corporate wellness deals, insurers, employers and partner platforms such as Amazon.

An annual diagnostic subscription bundling a full-body checkup and follow-up tests; paused in April 2026 for refinement before relaunch.

Premium genetic panels such as the Nutri DNA Test.

Orange Health recorded Rs 84 crore in revenue against a Rs 81 crore net loss in FY25, disclosed around its Series C fundraise -- indicating total costs ran roughly double revenue that year.

Orange Health's most mature market, Bengaluru, has reached 20% EBITDA profitability, and the company says all its other city operations are now operationally profitable too, even though group-level profitability is still a forward target.

The company is aiming for full group-level profitability within eight to nine quarters (first half of 2028), even as it keeps investing to double its walk-in outlets to 150 by the end of FY26, up from 70+ previously -- a deliberate near-term cost ahead of company-wide breakeven.